Molecular Basis of Voltage-Dependent Potassium Currents in
Porcine Granulosa Cells
DIANE E. MASON, KATHY E. MITCHELL, YAN LI, MELISSA R. FINLEY, and LISA C. FREEMAN
Departments of Anatomy and Physiology (K.E.M., Y.L., M.R.F., L.C.F.) and Clinical Sciences (D.E.M.), College of Veterinary Medicine, Kansas
State University, Manhattan, Kansas
Received March 9, 2001; accepted July 20, 2001 This paper is available online at http://molpharm.aspetjournals.org
ABSTRACT
The major objective of this study was to elucidate the molecular
bases for K
current diversity in porcine granulosa cells (GC).
Two delayed rectifier K
currents with distinct electrophysio-
logical and pharmacological properties were recorded from
porcine GC by using whole-cell patch clamp: 1) a slowly acti-
vating, noninactivating current (I
Ks
) antagonized by clofilium,
293B, L-735,821, and L-768,673; and 2) an ultrarapidly activat-
ing, slowly inactivating current (I
Kur
) antagonized completely by
clofilium and 4-aminopyridine and partially by tetraethylammo-
nium, charybdotoxin, dendrotoxin, and kaliotoxin. The molec-
ular identity of the K
channel genes underlying I
Ks
and I
Kur
was
examined using reverse transcription-polymerase chain reac-
tion and immunoblotting to detect K
channel transcripts and
proteins. We found that GC could express multiple voltage-
dependent K
(Kv) channel subunits, including KCNQ1,
KCNE1, Kv1.1, Kv1.2, Kv1.3, Kv1.4, Kv1.5, Kv1.6, Kv1.3, and
Kv2. Coimmunoprecipitation was used to establish the het-
ero-oligomeric nature of granulosa cell Kv channels. KCNE1
and KCNQ1 were coassociated in GC, and their expression
coincided with the expression of I
Ks
. Extensive coassociation of
the various Kv - and -subunits was also documented, sug-
gesting that the diverse electrophysiological and pharmacolog-
ical properties of I
Kur
currents may reflect variation in the com-
position and stoichiometry of the channel assemblies, as well
as differences in post-translational modification of contributing
Kv channel subunits. Our findings provide an essential back-
ground for experimental definition of granulosa K
channel
function(s). It will be critical to define the functional roles of
specific GC K
channels, because these proteins may repre-
sent either novel targets for assisted reproduction or potential
sites of drug toxicity.
Granulosa cells (GC) surround the oocyte within the ovar-
ian follicle and play an essential role in creating the condi-
tions required for follicular development, ovulation, fertiliza-
tion, and implantation (Salustri et al., 1993). During
folliculogenesis, GC undergo a series of mitotic divisions (pro-
liferation) then acquire gonadotropin receptors and enhanced
steroidogenic activity (differentiation). Autocrine-paracrine
and endocrine regulation of the granulosa cell maturation
have been extensively investigated and much is known about
the specific roles of various growth factors, hormones, trans-
membrane receptors, and second messengers (Steele and
Leung, 1993). In contrast, the functional significance of volt-
age-dependent ion channels in GC is far from understood.
It has been reported that GC can generate action poten-
tials (Mealing et al., 1994), and indirect evidence suggests
that modulation of granulosa cell electrical activity may pro-
vide a means to regulate cell function (Mattioli et al., 1990,
1991, 1993; Kusaka et al., 1993). For example, granulosa cell
depolarization has been described as a consistent feature of
oocyte maturation in different experimental systems (Mat-
tioli et al., 1990). Voltage-gated potassium currents with
distinct electrophysiological and pharmacological properties
have been described in both acutely isolated and cultured
GC, and have been shown to regulate granulosa cell resting
These studies were supported by National Institutes of Heath grants
HD34235 and HD36002 (to L.F.). D.E.M. and K.E.M. contributed equally to
this study.
ABBREVIATIONS: GC, granulosa cells; Kv1, voltage-gated K
channel subfamily 1 member; HRP, horseradish peroxidase; ECL, enhanced
chemiluminescence; FSH, follicle-stimulating hormone; MK-499, [()-N-{1'-(6-cyano-1,2,3,4-tetrahydro-2(R)-naphthalenyl)-3,4-dihydro-4(R)-
hydroxyspiro(2H-1-benzopyran-2,4'-piperidin)-6-yl]methanesulfonamide]; 293B, 4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchro-
mane; LY97241, 4-ethyl-N-heptyl-4-nitrobenzenebutanamine ethanedioic acid; L735,821, (R)-2(ethylene-2,4-dichlorophenyl)-N-[2-oxo-5-phenyl-
1-methyl-2,3-dihydro-1H-benzol[e][1,4]diazepin-3-yl]acetamide; L768,673, (R)-2-(2,4-trifluoromethylphenyl)-N-[2-oxo-5-phenyl-1-(2,2,2-
trifluoroethyl)-2,3-dihydro-1H-benzol[e][1,4]diazepin-3-yl]-acetamide; HEK, human embryonic kidney; HERG, human ether-a-go-go-related gene;
PCR, polymerase chain reaction; DMEM, Dulbecco’s modified Eagle’s medium; I
Ks
, slow delayed rectifier K
current; I
Kur
, ultra-rapid delayed
rectifier K
current; bp, base pair; PAGE, polyacrylamide gel electrophoresis; TBS, Tris-buffered saline; PNGase-F, peptide-N-glycosidase F;
4-AP, 4-aminopyridine; TEA, tetraethylammonium; CTX, charybdotoxin; DTX, dendrotoxin; KTX, kaliotoxin; MTX, margatoxin; CHO, Chinese
hamster ovary; RT, reverse transcription.
0026-895X/02/6101-201–213$3.00
MOLECULAR PHARMACOLOGY Vol. 61, No. 1
Copyright © 2002 The American Society for Pharmacology and Experimental Therapeutics 941/953855
Mol Pharmacol 61:201–213, 2002 Printed in U.S.A.
201
at ASPET Journals on May 5, 2017 molpharm.aspetjournals.org Downloaded from